ArticlePLOS digital health2025
Characterizing the role of early life factors in machine learning-based multimorbidity risk prediction.
Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent evidence suggests that psycho-cardio-metabolic (PCM) multimorbidity finds its origins in exposure to early-life factors (ELFs), making the exploration of this association crucial for understanding and effective management of these complex health issues. Moreover, risk prediction models for cardiovascular diseases (CVD) and diabetes, as recommended by current clinical guidelines, typically demonstrate sub-optimal performance in clinically relevant sub-populations where these ELFs may play a substantial role. Our methodological approach investigates the contribution of ELFs to machine-learning-based risk prediction models for comorbid populations, incorporating a wide set of early-life and proximal variables, with a special focus on prenatal and postnatal ELFs. To address the complexity of integrating diverse early-life and proximal factors, we leverage models capable of handling high-dimensional, heterogeneous data sources to enhance prediction accuracy in complex clinical populations. The long-term predictive ability of ELFs, along with their influence on model decisions, is assessed with the learned models, and global and local model-agnostic interpretative techniques allow us to elucidate some interactions leading to multimorbidity. The data for this study is derived from the UK Biobank, showcasing both the strengths and limitations inherent in utilizing a single, large-scale database for such research. Our results show enhanced predictive performance for CVD (AUC-ROC: +7.9%, Acc: +14.7%, Cohen's d: 1.5) among individuals with concurrent mental health issues (depression or anxiety) and diabetes. Similarly, we demonstrate improved diabetes risk prediction (AUC-ROC: +12.3%, Acc: +13.5%, Cohen's d: 2.5) in those with concurrent mental health conditions and CVD. The inspection of these models, which integrate a large set of ELFs and other predictors (including the 7-core Framingham and UKDiabetes variables), provides key information that could lead to a more profound understanding of psycho-cardio-metabolic multimorbidity. Our findings highlight the utility of incorporating life-course factors into risk models. Integrating a diverse range of physiological, psychological, and ELFs becomes particularly pertinent in the context of multimorbidity.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.